Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) is one of the 11 best debt-free stocks to invest in right now. The company ...

Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.

New York State Common Retirement Fund trimmed its Regeneron stake by 5% in Q1, selling over 6,800 shares worth millions.

Analysts have recently evaluated Regeneron Pharmaceuticals and provided 12-month price targets. The average target is $769.35, accompanied by a high estimate of $975.00 and a low estimate of $547.00.

Major indices were in the green earlier on Wednesday as traders digested more bank earnings and another key inflation report.

Wall Street stocks delivered a mixed performance on Tuesday as market participants digested key inflation data and mixed Q2 ...

Morgan Stanley slightly lowered its price target for Regeneron Pharmaceuticals while maintaining an overweight rating, ...

House passage of the Senate’s GENIUS Act, which would stand up a U.S. regulatory framework for cryptocurrencies pegged to the value of the dollar, would deliver major crypto legislation to the Oval ...

Enphase Energy (ENPH) closed the most recent trading day at $41.86, moving 2.59% from the previous trading session.

Read about Regeneron Pharmaceuticals Inc (REGN:XNAS) stock and today's latest news and financial updates.